EarningsQ3 2021 Earnings Report

Eledon Pharmaceuticals (2TK) Q3 2021 Earnings Report

1 Followers

DE:2TK Q3 2021 EPS Results

Actual EPS-€0.59

Consensus EPS-€0.56

Beat/MissMissed by -€0.03

One Year Ago EPS-€4.93

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ3 2021

Date11/11/2021

TimeAfter Close

Conference CallThursday, November 11, 2021

DE:2TK Upcoming Earnings

Eledon Pharmaceuticals's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 18, 2026	2026 (Q3)	-0.17 / -	-0.188	―
Aug 13, 2026	2026 (Q2)	-0.14 / -0.24	-0.116	-107.69% (-0.13)
May 13, 2026	2026 (Q1)	-0.16 / -0.30	-0.072	-312.50% (-0.22)
Mar 19, 2026	2025 (Q4)	-0.18 / -0.10	-0.573	82.81% (+0.47)
Nov 14, 2025	2025 (Q3)	-0.22 / -0.19	-0.286	34.37% (+0.10)
Aug 14, 2025	2025 (Q2)	-0.21 / -0.12	-0.949	87.74% (+0.83)
May 14, 2025	2025 (Q1)	-0.24 / -0.07	-0.304	76.47% (+0.23)
Mar 20, 2025	2024 (Q4)	-0.28 / -0.57	-0.286	-100.00% (-0.29)
Nov 12, 2024	2024 (Q3)	-0.28 / -0.29	-0.313	8.57% (+0.03)
Aug 08, 2024	2024 (Q2)	-0.27 / -0.32	-0.358	10.00% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed